 | total:803
[2003]
| 621. | Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2..[Arch Toxicol,77(5),(2003),267-273]Obara Naoshi, Imagawa Shigehiko, Nakano Yoko, Suzuki Norio, Yamamoto Masayuki, Nagasawa Toshiro
 |
| |
| 622. | EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice..[Free Radic Biol Med,34(10),(2003),1236-1242]Hirayama Aki, Yoh Keigyou, Nagase Sohji, Ueda Atsushi, Itoh Ken, Morito Naoki, Hirayama Kouichi, Takahashi Satoru, Yamamoto Masayuki, Koyama Akio
|
| |
| 623. | Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts..[Biochem Biophys Res Commun,305(2),(2003),271-277]Aono Junko, Yanagawa Toru, Itoh Ken, Li Baojie, Yoshida Hiroshi, Kumagai Yoshito, Yamamoto Masayuki, Ishii Tetsuro
|
| |
| 624. | Functional analysis of basic transcription element binding protein by gene targeting technology..[Mol Cell Biol,23(7),(2003),2489-2500]Morita Masanobu, Kobayashi Akira, Yamashita Toshiharu, Shimanuki Tomomasa, Nakajima Osamu, Takahashi Satoru, Ikegami Shiro, Inokuchi Kaoru, Yamashita Keisuke, Yamamoto Masayuki, Fujii-Kuriyama Yoshiaki
|
| |
| 625. | Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles..[Genes Cells,8(4),(2003),379-391]Itoh Ken, Wakabayashi Nobunao, Katoh Yasutake, Ishii Tetsuro, O'Connor Tania, Yamamoto Masayuki
|
| |
| 626. | Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice..[Carcinogenesis,24(3),(2003),461-467]Ramos-Gomez Minerva, Dolan Patrick M, Itoh Ken, Yamamoto Masayuki, Kensler Thomas W
|
| |
| 627. | 二次性貧血に対する新規治療薬の開発.[医学のあゆみ,204(12),(2003),903-904]今川 重彦, 中野 陽子, 小原 直, 鈴木 教郎, 土肥 武, 児玉 龍彦, 長澤 俊郎, 山本 雅之
|
| |
| 628. | HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin..[EMBO J,22(5),(2003),1134-1146]Morita Masanobu, Ohneda Osamu, Yamashita Toshiharu, Takahashi Satoru, Suzuki Norio, Nakajima Osamu, Kawauchi Shimako, Ema Masatsugu, Shibahara Shigeki, Udono Tetsuo, Tomita Koji, Tamai Makoto, Sogawa Kazuhiro, Yamamoto Masayuki, Fujii-Kuriyama Yoshiaki
|
| |
| 629. | Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival..[J Biol Chem,278(10),(2003),8135-8145]Kwak Mi-Kyoung, Wakabayashi Nobunao, Itoh Ken, Motohashi Hozumi, Yamamoto Masayuki, Kensler Thomas W
|
| |
| 630. | Gene expression of detoxifying enzymes in AhR and Nrf2 compound null mutant mouse..[Biochem Biophys Res Commun,303(1),(2003),105-111]Noda Shuhei, Harada Nobuhiko, Hida Azumi, Fujii-Kuriyama Yoshiaki, Motohashi Hozumi, Yamamoto Masayuki
|
| |
| 631. | Regulation of YB-1 gene expression by GATA transcription factors..[Biochem Biophys Res Commun,303(1),(2003),140-145]Yokoyama Hisayuki, Harigae Hideo, Takahashi Shinichiro, Takahashi Satoru, Furuyama Kazumichi, Kaku Mitsuo, Yamamoto Masayuki, Sasaki Takeshi
|
| |
| 632. | Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response..[Mol Cell Biol,23(4),(2003),1163-1174]Katsuoka Fumiki, Motohashi Hozumi, Tamagawa Yuna, Kure Shigeo, Igarashi Kazuhiko, Engel James Douglas, Yamamoto Masayuki
|
| |
| 633. | Hemogenic and nonhemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis..[Blood,101(3),(2003),886-893]Hirai Hideyo, Ogawa Minetaro, Suzuki Norio, Yamamoto Masayuki, Breier Georg, Mazda Osam, Imanishi Jiro, Nishikawa Shin-Ichi
|
| |
| 634. | Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts..[Blood,101(3),(2003),1188-1193]Harigae Hideo, Nakajima Osamu, Suwabe Naruyoshi, Yokoyama Hisayuki, Furuyama Kazumichi, Sasaki Takeshi, Kaku Mitsuo, Yamamoto Masayuki, Sassa Shigeru
|
| |
| 635. | 新規エリスロポエチン発現促進剤(K-7174) 腎性貧血への試み.[医学のあゆみ,204(4),(2003),291-292]今川 重彦, 中野 陽子, 小原 直, 鈴木 教郎, 土肥 武, 児玉 龍彦, 長澤 俊郎, 山本 雅之
|
| |
[2002]
| 636. | A minigene containing four discrete cis elements recapitulates GATA-1 gene expression in vivo..[Genes Cells,7(12),(2002),1243-1254]Ohneda Kinuko, Shimizu Ritsuko, Nishimura Shigeko, Muraosa Yasushi, Takahashi Satoru, Engel James Douglas, Yamamoto Masayuki
|
| |
| 637. | GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins..[Blood,100(10),(2002),3512-3520]Ezoe Sachiko, Matsumura Itaru, Nakata Soichi, Gale Karin, Ishihara Katsuhiko, Minegishi Naoko, Machii Takashi, Kitamura Toshio, Yamamoto Masayuki, Enver Tariq, Kanakura Yuzuru
|
| |
| 638. | Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression..[J Biol Chem,277(47),(2002),44765-44771]Sasaki Hiromi, Sato Hideyo, Kuriyama-Matsumura Kazumi, Sato Kanako, Maebara Kanako, Wang Hongyu, Tamba Michiko, Itoh Ken, Yamamoto Masayuki, Bannai Shiro
|
| |
| 639. | Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality..[Blood,100(7),(2002),2279-2288]Suzuki Norio, Ohneda Osamu, Takahashi Satoru, Higuchi Masato, Mukai Harumi Y, Nakahata Tatsutoshi, Imagawa Shigehiko, Yamamoto Masayuki
|
| |
| 640. | Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene..[EMBO J,21(19),(2002),5216-5224]Sun Jiying, Hoshino Hideto, Takaku Kazuaki, Nakajima Osamu, Muto Akihiko, Suzuki Hiroshi, Tashiro Satoshi, Takahashi Satoru, Shibahara Shigeki, Alam Jawed, Taketo Makoto M, Yamamoto Masayuki, Igarashi Kazuhiko
|
| |
| |
